Search Results - D. Redding

P1048: MYF3001: A RANDOMIZED OPEN LABEL, PHASE 3 STUDY TO EVALUATE IMETELSTAT VERSUS BEST AVAILABLE THERAPY IN PATIENTS WITH INTERMEDIATE-2 OR HIGH-RISK MYELOFIBROSIS REFRACTORY TO... by J. Mascarenhas, C. N. Harrison, J.-J. Kiladjian, R. S. Komrokji, S. Koschmieder, A. M. Vannucchi, T. Berry, D. Redding, L. Sherman, S. Dougherty, L. Peng, L. Sun, F. Huang, Y. Wan, F. M. Feller, A. Rizo, S. Verstovsek

Get full text